Does donating blood on TRT actually reduce health risks?

What did @kmartfit actually say?

The short version: he's been on TRT for over three years, never needed to donate blood, and credits that to good medical oversight. He says that if you're donating blood regularly, your dose is probably too high or your body is responding abnormally, and adjustments should be made. He also pitches the clinic he uses, which operates in all 50 states and costs him under $200 a month for testosterone, clomiphene, supplies, telemedicine visits, and quarterly bloodwork.

The core medical claim is actually reasonable. The pitch at the end is a sponsored recommendation dressed up as personal advice, and that distinction matters when we're talking about someone else's hormone therapy.

Does the science back this up?

Partly. TRT does raise hematocrit in many patients, but not all of them, and the creator is right that not everyone ends up needing therapeutic phlebotomy. The problem is how casually he frames it.

Exogenous testosterone stimulates erythropoiesis, the production of red blood cells, through increases in erythropoietin and direct effects on bone marrow. The result is often elevated hematocrit and hemoglobin. A 2017 study by Bachman et al. in the Journal of Clinical Endocrinology and Metabolism found that hematocrit exceeded 54% in roughly 5.7% of men on testosterone therapy in the Testosterone Trials, a figure that was significantly higher than placebo. A 2021 review by Lincoff et al., which contributed to the TRAVERSE trial design, flagged polycythemia as one of the most consistently documented adverse effects of testosterone therapy across formulations.

Whether any individual patient hits that threshold depends on their dose, the formulation, their baseline hematocrit, iron stores, sleep apnea status, and altitude. So yes, some men on well-managed TRT never need to donate blood. But the creator implies this is the expected outcome of good care, when the data say it's more like a best-case scenario.

What did they get wrong (or right)?

He got the directional logic right: higher doses and suboptimal monitoring increase the likelihood of polycythemia requiring phlebotomy. That's real. The 2023 TRAVERSE trial published in the New England Journal of Medicine by Lincoff et al. confirmed that polycythemia was more common with testosterone than placebo, and it was dose-dependent in practice across observational data.

What he got wrong, or at minimum oversimplified, is the framing that needing to give blood is a sign of a bad doctor. Some patients develop elevated hematocrit even on conservative, well-monitored doses. Genetics, sleep apnea, and iron status all play roles that have nothing to do with your prescriber's competence. Phlebotomy in those cases isn't a failure, it's an appropriate management tool.

His personal experience, three years, hematocrit in range, no phlebotomy needed, is plausible and not suspicious. But generalizing from one patient's trajectory to a prescribing philosophy is where the content goes sideways.

What should you actually know?

If you're on TRT, hematocrit and hemoglobin should be monitored regularly regardless of whether you feel fine. The Endocrine Society recommends checking hematocrit at baseline, then at 3 to 6 months, then annually once stable. If hematocrit climbs above 54%, dose reduction or phlebotomy is standard of care, not a sign that something went wrong with your prescriber.

The creator's comment that quarterly bloodwork is included in his plan is actually a meaningful point. Many TRT patients, particularly those using cash-pay telehealth, skip labs to save money. That's where real risk accumulates. Elevated hematocrit without symptoms is clinically silent until it isn't. Cardiovascular events linked to polycythemia don't announce themselves in advance.

On the clinic pitch: a telehealth TRT provider operating in all 50 states that ships medication and includes labs for under $200 a month may be legitimate, or it may not be. That is not something to evaluate from a TikTok comment thread. If you're considering any TRT provider, verify their prescribers are licensed in your state, confirm the compounded testosterone they're sending has been prepared by an FDA-registered 503B outsourcing facility, and do not assume pricing signals quality in either direction.

Is there a bottom line here?

The creator's personal experience is not fabricated, and the general principle that good monitoring reduces the need for phlebotomy has some grounding. But this video frames one man's outcome as a benchmark for what TRT should look like, and it ends with a referral link dressed up as a recommendation. Neither of those things should guide your medical decisions. Talk to a licensed provider who has actually reviewed your labs, not someone whose hematocrit happens to be fine.